Meritage Portfolio Management »

United Therapeutics Corporation shares owned by Meritage Portfolio Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Meritage Portfolio Management from 13F filings

Historical chart of Meritage Portfolio Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Meritage Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Meritage Portfolio Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $3.4M 55k 60.87
2012-12-31 $2.8M 52k 53.42

More positions owned by Meritage Portfolio Management

Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc Cl A Common (GOOGL)
Broadcom Common (AVGO)
Amazon Common (AMZN)
Nvidia Corp Common (NVDA)
Fortinet Common (FTNT)
Exxon Mobil Corp Common (XOM)
Novo-nordisk A S Common (NVO)
Asml Holding Nv Common (ASML)
Alibaba Group Holding Common (BABA)
Booking Holdings Common (BKNG)
Mastercard Common (MA)
Kla Corporation Common (KLAC)
Arista Networks Common (ANET)

View all positions for Meritage Portfolio Management

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation